Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Eli Lilly & Co. (LLY) Tops Q2 EPS by 5c, Revenue Beats, Updates FY Guidance
July 30, 2019 6:27 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.50, $0.05 better than the analyst estimate of $1.45. Revenue for the quarter came in at $5.64 billion versus the consensus estimate of $5.59 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2019 EPS of $5.67-$5.77, versus the... More
